Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence YLQGAKIPKPEASFSPR
Primary information
sequence IDSeq_9779
Peptide sequenceYLQGAKIPKPEASFSPR
CancerPDF_ID CancerPDF_ID1858, CancerPDF_ID12732,
PMID21136997,27058005
Protein NameInter-alpha-trypsin inhibitor heavy chain H4,Inter-alpha-trypsin inhibitor heavy chain H5
UniprotKB Entry NameITIH4_HUMAN,ITIH5_HUMAN
FluidSerum,Serum
M/Z1888.02068,1889.031
Charge1,NA
Mass (in Da)NA,NA
fdrNA,NA
Profiling TechniqueLC-MS,MALDI-TOF
Peptide Identification techniqueLC-MS-MS/MS,LC-MS/MS
Quantification TechniqueLC-ESI-MS,NA
Labelled/Label FreeLabel Free,Label Free
FDRNA,NA
CancerPDF_ID CancerPDF_ID1858, CancerPDF_ID12732,
p-ValueNA,"0.338,0.473,less than 0.01"
SoftwareMASCOT(v. 2.2.01),Proteome Discoverer
Length17,17
Cancer TypeColorectal cancer,Breast cancer
DatabaseSwissProt Database,SwissProt Database
ModificationNA,NA
Number of Patients30 patients and 30 healthy controls," 28 were diagnosed with Breast cancer, 27 remained cancer-free with BRCA carrier. Of the remaining patients, 39 were diagnosed with sporadic breast cancer (SBC), and 38 were healthy volunteers (WT)."
RegulationNA,"Upregulated with the fold change of 1.14 in breast cancer vs Cancer free patients with brca mutation, Upregulated in breast cancer vs sporadic breast cancer with fold change of 1.08, Upregulated in BC vs healthy with 1.244 fold change"
ValidationLeave One out Cross validation,NA
SensitivityNA,NA
SpecificityNA,NA
AccuracyNA,NA
Peptide AtlasNA
IEDB